Dynulta Tablet belongs to the class of medications called mineral supplements indicated for controlling serum phosphorus levels in adult chronic kidney disease patients on haemodialysis or peritoneal dialysis. 

Dynulta Tablet contains 'sucroferric oxyhydroxide'. It helps to lower phosphate levels in the blood and prevents complications caused by high phosphate levels in the blood, especially in dialysis patients who are unable to eliminate excess phosphate levels.

Dynulta Tablet should be taken as prescribed by your doctor. Dynulta Tablet can cause side effects such as diarrhoea, nausea, vomiting, constipation, and indigestion in some cases. These side effects are not universal and vary from person to person. Please consult your doctor if you experience any of the side effects persistently.

Do not take Dynulta Tablet if you are allergic to any of the contents, if you have/had haemochromatosis, or iron overload disorder. Before using this medication, inform your doctor of any medical issues you may have. Consult your doctor if you are pregnant or breastfeeding. The safety and efficacy of Dynulta Tablet in children blow 2years have not been established.

Dynulta Tablet contains sucroferric oxyhydroxide indicated for controlling serum phosphorus levels in adult chronic kidney disease patients on haemodialysis or peritoneal dialysis. Dynulta Tablet helps to lower phosphate levels in the blood and prevents issues caused by high phosphate levels in the blood, especially in dialysis patients who are unable to get rid of excess phosphate levels.

• Diarrhoea
• Nausea
• Vomiting
• Constipation
• Indigestion

Do not take Dynulta Tablet if you are allergic to any of the contents, if you have/had haemochromatosis, or iron overload disorder. Notify your doctor if you have/had inflammation of the peritoneum, stomach/intestinal surgery, stomach and/or liver problems. Before using this medication, tell your doctor about any health complications you have. Inform your doctor if you are taking any other medications. Consult your doctor if you are pregnant or nursing. 

Drug-Drug Interactions: Dynulta Tablet may interact with certain medications used to treat bladder cancer (erdafitinib), antibiotic (doxycycline), hormone (levothyroxine).

Drug-Food Interactions: Limit or quit the consumption of alcohol.

Drug-Disease Interactions: Dynulta Tablet may interact with disease conditions like hemochromatosis (extra iron builds up in the body).

• ERDAFITINIB
• DOXYCYCLINE
• LEVOTHYROXINE

• Reduce the amount of phosphorus in your foods and beverages.
• Eat low phosphorus foods such as sourdough bread, corn or rice cereals, cream of wheat, unsalted popcorn and some light-coloured sodas & lemonade.
• Avoid high phosphorus foods, including bran cereals, oatmeal, nuts, sunflower seeds, whole-grain bread and dark-coloured colas.

• To rule out the possibility of electrolyte imbalance, electrolyte levels should be monitored on a regular basis.

Hyperphosphatemia: Hyperphosphatemia is an electrolyte disorder characterised by an elevated phosphate level in the blood. Healthy kidneys balance phosphorus levels in the body by removing excess phosphorus from the blood. If you have kidney disease, your kidneys may not be able to eliminate excess phosphorus. It has the potential to be extremely harmful to one's health. High phosphorus levels do not always cause symptoms. Extra phosphorus in the blood can eliminate calcium from the bones and other parts of the body, resulting in low calcium (hypocalcemia).